ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,440,841 | -48.3% | 495,241 | -41.5% | 0.01% | -35.7% |
| Q2 2023 | $26,012,650 | +35.4% | 846,215 | +58.7% | 0.01% | +27.3% |
| Q1 2023 | $19,206,296 | -20.1% | 533,064 | -12.3% | 0.01% | -21.4% |
| Q4 2022 | $24,030,729 | +22.3% | 608,065 | +24.3% | 0.01% | +16.7% |
| Q3 2022 | $19,650,000 | +2.1% | 489,061 | +6.8% | 0.01% | +9.1% |
| Q2 2022 | $19,253,000 | +7.8% | 457,960 | -0.1% | 0.01% | +37.5% |
| Q1 2022 | $17,860,000 | +4.0% | 458,416 | +6.3% | 0.01% | 0.0% |
| Q4 2021 | $17,179,000 | +50.5% | 431,096 | +36.5% | 0.01% | +60.0% |
| Q3 2021 | $11,418,000 | +14.2% | 315,906 | +29.5% | 0.01% | 0.0% |
| Q2 2021 | $9,998,000 | +30.4% | 243,908 | +38.8% | 0.01% | +25.0% |
| Q1 2021 | $7,669,000 | -29.6% | 175,784 | -19.3% | 0.00% | -42.9% |
| Q4 2020 | $10,898,000 | +14239.5% | 217,727 | +11982.5% | 0.01% | – |
| Q3 2020 | $76,000 | – | 1,802 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |